Literature DB >> 18325309

New approaches to the concept of primary prevention of atherosclerosis.

Monique A Ford1, Thomas G Allison, Amir Lerman.   

Abstract

Our understanding of the etiology of atherosclerosis and the mechanisms by which conventional cardiovascular risk factors cause disease is incomplete. Atherosclerosis may be regarded as a process of continuous injury and abnormal repair. The diagnosis and treatment of the disease should be targeted to the various stages of this process, from the early stages of vascular injury to the stabilization of the vulnerable plaque. Several novel concepts in atherosclerosis have been elucidated in the past two decades. Novel biomarkers and imaging techniques for early subclinical atherosclerotic lesions may facilitate earlier primary prevention. Future primary prevention of atherosclerosis should incorporate these novel concepts for creation of individualized risk profiles and therapies.

Entities:  

Year:  2008        PMID: 18325309     DOI: 10.1007/s11936-008-0008-y

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  60 in total

Review 1.  Vaccination for atherosclerosis: a novel therapeutic paradigm.

Authors:  Prediman K Shah; Kuang-Yuh Chyu; Gunilla N Fredrikson; Jan Nilsson
Journal:  Expert Rev Vaccines       Date:  2004-12       Impact factor: 5.217

2.  The failure of torcetrapib: was it the molecule or the mechanism?

Authors:  Alan R Tall; Laurent Yvan-Charvet; Nan Wang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02       Impact factor: 8.311

3.  Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults.

Authors:  H C Stary
Journal:  Arteriosclerosis       Date:  1989 Jan-Feb

4.  Targeting C-reactive protein for the treatment of cardiovascular disease.

Authors:  Mark B Pepys; Gideon M Hirschfield; Glenys A Tennent; J Ruth Gallimore; Melvyn C Kahan; Vittorio Bellotti; Philip N Hawkins; Rebecca M Myers; Martin D Smith; Alessandra Polara; Alexander J A Cobb; Steven V Ley; J Andrew Aquilina; Carol V Robinson; Isam Sharif; Gillian A Gray; Caroline A Sabin; Michelle C Jenvey; Simon E Kolstoe; Darren Thompson; Stephen P Wood
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

5.  Association of sleep apnea and type II diabetes: a population-based study.

Authors:  Kevin J Reichmuth; Diane Austin; James B Skatrud; Terry Young
Journal:  Am J Respir Crit Care Med       Date:  2005-09-28       Impact factor: 21.405

6.  The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial.

Authors:  María-Isabel Covas; Kristiina Nyyssönen; Henrik E Poulsen; Jari Kaikkonen; Hans-Joachim F Zunft; Holger Kiesewetter; Antonio Gaddi; Rafael de la Torre; Jaakko Mursu; Hans Bäumler; Simona Nascetti; Jukka T Salonen; Montserrat Fitó; Jyrki Virtanen; Jaume Marrugat
Journal:  Ann Intern Med       Date:  2006-09-05       Impact factor: 25.391

Review 7.  Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient.

Authors:  Piero Montorsi; Paolo M Ravagnani; Stefano Galli; Andrea Salonia; Alberto Briganti; José P Werba; Francesco Montorsi
Journal:  Eur Urol       Date:  2006-07-28       Impact factor: 20.096

8.  Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.

Authors:  Michiel L Bots; Frank L Visseren; Gregory W Evans; Ward A Riley; James H Revkin; Charles H Tegeler; Charles L Shear; William T Duggan; Ralph M Vicari; Diederick E Grobbee; John J Kastelein
Journal:  Lancet       Date:  2007-07-14       Impact factor: 79.321

9.  Framingham risk score is related to carotid artery intima-media thickness in both white and black young adults: the Bogalusa Heart Study.

Authors:  Lyn Kieltyka; Elaine M Urbina; Rong Tang; M Gene Bond; Sathanur R Srinivasan; Gerald S Berenson
Journal:  Atherosclerosis       Date:  2003-09       Impact factor: 5.162

10.  Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study.

Authors:  Marijn C Meuwese; Erik S G Stroes; Stanley L Hazen; Joram N van Miert; Jan Albert Kuivenhoven; Robert G Schaub; Nicholas J Wareham; Robert Luben; John J P Kastelein; Kay-Tee Khaw; S Matthijs Boekholdt
Journal:  J Am Coll Cardiol       Date:  2007-06-21       Impact factor: 24.094

View more
  2 in total

1.  Coronary artery endothelial dysfunction is positively correlated with low density lipoprotein and inversely correlated with high density lipoprotein subclass particles measured by nuclear magnetic resonance spectroscopy.

Authors:  Monique A Ford; Joseph P McConnell; Shahar Lavi; Charanjit S Rihal; Abhiram Prasad; Gurpreet S Sandhu; Stacy J Hartman; Lilach O Lerman; Amir Lerman
Journal:  Atherosclerosis       Date:  2009-05-06       Impact factor: 5.162

Review 2.  The prevention and regression of atherosclerotic plaques: emerging treatments.

Authors:  Atul Ashok Kalanuria; Paul Nyquist; Geoffrey Ling
Journal:  Vasc Health Risk Manag       Date:  2012-09-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.